| Literature DB >> 35578755 |
Carlos Cortés1, Lili Liu2, Scarlet Luisa Berdin3,4, Pablo M Fernández-Corredoira1, Ruiyan Zhang2, Ulrich Schäfer5, María López6, José A Diarte1, Shengxian Tu7, Juan Luis Gutiérrez-Chico8,9.
Abstract
BACKGROUND: The agreement between single-projection Murray-based quantitative flow ratio (mQFR) and conventional three-dimensional quantitative flow ratio (3D-QFR) has not been reported hitherto.Entities:
Keywords: Murray law; computational physiology; coronary heart disease; coronary physiology; quantitative flow ratio; resting index; μQFR
Mesh:
Year: 2022 PMID: 35578755 PMCID: PMC9170317 DOI: 10.5603/CJ.a2022.0030
Source DB: PubMed Journal: Cardiol J ISSN: 1898-018X Impact factor: 3.487
Figure 1Paradigmatic example of both quantitative flow ratio (QFR) modalities: μQFR (A) and three-dimensional quantitative flow ratio (3D-QFR) (B).
Figure 2Flow chart; CABG — coronary artery bypass grafting; CTO — chronic total occlusion.
Descriptive statistics of patients, intervention and lesions.
| Patient level | N = 35 | Spanish cohort (n = 21) | Chinese cohort (n = 14) | P |
|---|---|---|---|---|
| Male | 25 (71.4%) | 14 (66.7%) | 11 (78.6%) | 0.445 |
| Age [years] (95% CI) | 65.8 (61.9–72.9) | 65.1 (59.6–70.6) | 66.9 (61.0–72.9) | 0.639 |
| BMI (95% CI) | 25.4 (24.2–26.7) | 26.6 (25.0–28.2) | 23.7 (22.1–25.4) | 0.016 |
| Cardiovascular risk factors: | ||||
| Hypertension | 28 (80.0%) | 18 (85.7%) | 10 (71.4%) | 0.301 |
| Hypercholesterolemia | 16 (45.7%) | 16 (76.2%) | 8 (57.1%) | 0.505 |
| Diabetes mellitus: | 10 (28.6%) | 8 (38.1%) | 2 (14.3%) | 0.127 |
| Type 2 on OAD | 8 (22.9%) | 6 (28.6%) | 2 (14.3%) | 0.324 |
| Type 2 on insulin | 2 (5.7%) | 2 (9.5%) | 0 (0.0%) | 0.234 |
| Smoking: | 20 (57.1%) | 12 (57.1%) | 8 (57.1%) | 1.000 |
| Previous smoker | 8 (22.9%) | 5 (23.8%) | 3 (21.4%) | 0.869 |
| Current smoker | 12 (34.3%) | 7 (33.3%) | 5 (35.7%) | 0.884 |
| Previous MI | 7 (20.0%) | 5 (23.8%) | 2 (14.3%) | 0.490 |
| Previous revascularization | 7 (20.0%) | 4 (19.1%) | 3 (21.4%) | 0.863 |
| GFR [mL/min] (95% CI) | 77.4 (68.5–86.2) | 75.1 (60.8–89.4) | 80.8 (72.3–89.3) | 0.530 |
| Hemoglobin [g/dL] (95% CI) | 14.0 (13.5–14.5) | 14.3 (13.5–15.0) | 13.5 (12.8–14.2) | 0.141 |
| LVEF [%] (95% CI) | 58.8 (55.2–62.4) | 54.7 (49.6–59.8) | 64.9 (62.4–67.5) | 0.002 |
|
| ||||
| Syntax score (95% CI) | 9.3 (6.9–11.6) | 9.3 (6.2–12.4) | 9.2 (5.1–13.4) | 0.973 |
| Fluoroscopy [min] (95% CI) | 12.2 (9.0–15.4) | 12.8 (8.7–16.9) | 11.3 (5.5–17.1) | 0.645 |
|
| 0.004 | |||
| Stable disease | 29 (82.9%) | 21 (100.0%) | 8 (57.1%) | |
| Unstable angina | 5 (14.7%) | 0 (0.0%) | 5 (35.7%) | |
| Non-ST-elevation MI | 1 (2.9%) | 0 (0.0%) | 1 (7.1%) | |
|
|
|
|
| 0.947 |
| LAD | 34 (34.7%) | 20 (35.7%) | 14 (33.3%) | |
| LCX | 33 (33.7%) | 19 (33.9%) | 14 (33.3%) | |
| RCA | 31 (31.6%) | 17 (30.4%) | 14 (33.3%) | |
| Lesions (3D-QFR ≤ 0.80) | 24 (24.5%) | 18 (32.1%) | 6 (14.3%) | 0.057 |
| Calcification: | ||||
| None to little | 78 (79.6%) | 42 (75.0%) | 36 (87.7%) | 0.216 |
| Moderate to severe | 20 (20.4%) | 14 (25.0%) | 6 (14.3%) | 0.216 |
| Lesion length [mm] | 20.99 (18.0–24.0) | 24.30 (19.5–29.1) | 17.05 (13.1–21.0) | 0.025 |
| RVD [mm] | 2.60 (2.5–2.7) | 2.56 (2.4–2.8) | 2.70 (2.5–2.9) | 0.337 |
| MLD [mm] | 1.62 (1.5–1.8) | 1.5 (1.3–1.6) | 1.8 (1.6–2.1) | 0.018 |
| DS [%] | 38.37 (34.8–42.0) | 41.06 (36.9–45.2) | 31.07 (24.7–37.4) | 0.008 |
|
| 0.82 (0.78–0.87) | 0.80 (0.74–0.86) | 0.85 (0.77–0.94) | 0.250 |
|
| 0.81 (0.76–0.85) | 0.79 (0.73–0.85) | 0.85 (0.77–0.94) | 0.204 |
Data presented as counts (percent), mean (standard deviation) or median (P25 – P75); 3D-QFR — three-dimensional quantitative flow ratio; BMI — body mass index; CI — confidence interval; DS — diameter stenosis; GFR — glomerular filtration rate by Cockroft-Gault method; LAD — left anterior descending artery; LCX — left circumflex artery; LVEF — left ventricular ejection fraction; MLD — minimal lumen diameter; MI — myocardial infarction; OAD — oral antidiabetics; PCI — percutaneous coronary intervention; RCA — right coronary artery; RVD — reference vessel diameter; μQFR (microQFR) — single angiographic view quantitative flow ratio
Figure 3Agreement between three-dimensional quantitative flow ratio (3D-QFR) and single angiographic view quantitative flow ratio (μQFR) estimated by orthogonal regression line in panel A (Passing-Bablok method) and Bland-Altman graphics in panel B.